Bayer, J&J in frame for bigger anti-clotting market opportunity | | FRANKFURT (Reuters) - Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and heart attacks in patients with severe atherosclerosis by 24 percent, raising the prospects of billions more in sales. |
| |
Why teens need to understand care plans for dying parents | | (Reuters Health) - When children lose a parent during adolescence, their mental health as young adults may depend on how comfortable they were with the treatment and support provided at the end of their parents’ lives, a recent study suggests. |
| |
Smoking tied to frailty in older adults | | Reuters Health - Older adults who smoke are more likely to become physically frail than their counterparts who are former smokers or never used tobacco products, a recent study suggests. |
| |
| | |